These data reinforce our genetic evidence supporting a role for the tumour suppressor gene Hpo in ALS pathogenesis and provide a landscape of molecular interactions that can promote the formulation of additional mechanistic hypotheses to be experimentally validated. This evidence concerns the gene GFER and amyotrophic lateral sclerosis.